There is no further explanation from the government. Dinesh Dua, chairman of the Pharmaceuticals Export Promotion Council of India, told Reuters that acute shortages could occur in the next months if the virus-related disruptions in production and supply chains continue. A large proportion of the low-cost generic pharmaceuticals come from India. The country receives about 70 percent of its active ingredients and medicinal products from China and further processes a large part of them for export.
The supply of the following Indian active ingredients and medicinal products, as well as formulations thereof, is now restricted:
Fierce Pharma: Coronavirus spurs India to restrict exports of 2 dozen drugs